STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 203, Issue 11, Pages 3078-3085
Publisher
The American Association of Immunologists
Online
2019-10-24
DOI
10.4049/jimmunol.1900389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia
- (2018) Md Kamrul Hasan et al. BLOOD
- STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells
- (2018) Uri Rozovski et al. Oncotarget
- Constitutive Phosphorylation of STAT3 by the CK2–BLNK–CD5 Complex
- (2017) Uri Rozovski et al. MOLECULAR CANCER RESEARCH
- High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
- (2016) B. Cui et al. BLOOD
- Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia
- (2015) P. Janovska et al. CLINICAL CANCER RESEARCH
- Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
- (2015) Jian Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic plasticity in CLL: adaptation to the hypoxic niche
- (2015) K M Koczula et al. LEUKEMIA
- Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
- (2015) U. Rozovski et al. MOLECULAR CANCER RESEARCH
- Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival
- (2015) Valentina Trimarco et al. Oncotarget
- ROR1, an embryonic protein with an emerging role in cancer biology
- (2014) Nicholas Borcherding et al. Protein & Cell
- Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
- (2013) A. Ferrajoli et al. BLOOD
- Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells
- (2013) Uri Rozovski et al. Molecular Cancer
- The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- PDGF and PDGF receptors in glioma
- (2012) Inga Nazarenko et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Wnt5a: its signalling, functions and implication in diseases
- (2011) A. Kikuchi et al. Acta Physiologica
- Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway
- (2011) Dan Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- STAT-3 Activates NF- B in Chronic Lymphocytic Leukemia Cells
- (2011) Z. Liu et al. MOLECULAR CANCER RESEARCH
- STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells
- (2010) I. Hazan-Halevy et al. BLOOD
- Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells
- (2010) Ping Li et al. PLoS One
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
- (2008) Amir H. DaneshManesh et al. INTERNATIONAL JOURNAL OF CANCER
- Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase
- (2008) Yan Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started